Investigation alert: the gross law firm notifies shareholders of regeneron pharmaceuticals, inc. of an investigation and potential class action lawsuit - (nasdaq: regn)

New york , july 12, 2023 /prnewswire/ -- the gross law firm issues the following notice to shareholders of regeneron pharmaceuticals, inc.: the investigation focuses on whether the company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. regeneron received a response letter from the fda on june 27, 2023, declining to approve its application for an 8mg dose of aflibercept, marketed in the u.s. as eylea.
REGN Ratings Summary
REGN Quant Ranking